Table 1 Patients characteristics

Age:

   ≤ 65

43 (34.4%)

   > 65 e ≤ 75

57 (45.6%)

   > 75

25 (20.0%)

Highest serum PSA level (ng/ml):

   ≤ 10

77 (61.6%)

   > 10 e < 20

31 (24.8%)

   ≥20

17 (13.6%)

Stage (AJCC 1997):

   T2aN0M0 or lower

88 (70.4%)

   T2bN0M0 or higher

37 (29.6%)

Gleason Score:

   ≤ 6

63 (50.4%)

   7

49 (39.2%)

8 – 10

13 (10.4%)

Exclusive radiotherapy treatment

90 (72.0%)

Post-operative radiotherapy:

   adjuvant treatment

16 (12.8)

   PSA-relapse rescue

19 (15.2%)

Neo-adjuvant hormonal therapy

57 (45.6%)